4//SEC Filing
Schroeder Mark S 4
Accession 0001127602-25-007615
CIK 0000920148other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:41 AM ET
Size
8.7 KB
Accession
0001127602-25-007615
Insider Transaction Report
Form 4
Schroeder Mark S
EVP, Pres Diagnostics & COO
Transactions
- Exercise/Conversion
Common Stock
2025-02-28$131.43/sh+3,903$512,971→ 10,299.143 total - Sale
Common Stock
2025-02-28$249.23/sh−5,339$1,330,639→ 4,960.143 total - Exercise/Conversion
Non-qualified Stock Options
2025-02-28−3,903→ 0 totalExercise: $131.43From: 2020-02-12Exp: 2029-02-11→ Common Stock (3,903 underlying)
Footnotes (3)
- [F1]Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- [F3]The options vested in three equal annual installments beginning on the date reflected in this column.
Documents
Issuer
LABCORP HOLDINGS INC.
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001793112
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:41 AM ET
- Size
- 8.7 KB